Cargando…
Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism
Drug addiction remains a prevalent and fatal disease worldwide that carries significant social and economic impacts. Recent reports suggest illicit pregabalin (Lyrica) use may be increasing among youth, however the addictive potential of pregabalin has not been well established. Drug seeking behavio...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805907/ https://www.ncbi.nlm.nih.gov/pubmed/31641170 http://dx.doi.org/10.1038/s41598-019-51556-4 |
_version_ | 1783461503377080320 |
---|---|
author | Althobaiti, Yusuf S. Almalki, Atiah Alsaab, Hashem Alsanie, Walaa Gaber, Ahmed Alhadidi, Qasim Hardy, Ana Maria Gregio Nasr, Abdulrahman Alzahrani, Omar Stary, Creed M. Shah, Zahoor A. |
author_facet | Althobaiti, Yusuf S. Almalki, Atiah Alsaab, Hashem Alsanie, Walaa Gaber, Ahmed Alhadidi, Qasim Hardy, Ana Maria Gregio Nasr, Abdulrahman Alzahrani, Omar Stary, Creed M. Shah, Zahoor A. |
author_sort | Althobaiti, Yusuf S. |
collection | PubMed |
description | Drug addiction remains a prevalent and fatal disease worldwide that carries significant social and economic impacts. Recent reports suggest illicit pregabalin (Lyrica) use may be increasing among youth, however the addictive potential of pregabalin has not been well established. Drug seeking behavior and chronic drug use are associated with deficits in glutamate clearance and activation of postsynaptic glutamatergic receptors. In the current study, we investigated the abuse potential of pregabalin using conditioned place preference (CPP) paradigm. Different doses of pregabalin (30, 60, 90, and 120 mg/kg) were used to assess the seeking behavior in mice. Glutamate homeostasis is maintained by glutamate transporter type-1 (GLT-1), which plays a vital role in clearing the released glutamate from synapses and drug seeking behavior. Therefore, we investigated the role of glutamate in pregabalin-seeking behavior with ceftriaxone (CEF), a potent GLT-1 upregulator. Mice treated with pregabalin 60 and 90 mg/kg doses demonstrated drug seeking-like behavior, which was significantly blocked by CEF pretreatment. These results suggest that pregabalin-induced CPP was successfully modulated by CEF which could serve as a lead compound for developing treatment for pregabalin abuse. |
format | Online Article Text |
id | pubmed-6805907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68059072019-10-24 Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism Althobaiti, Yusuf S. Almalki, Atiah Alsaab, Hashem Alsanie, Walaa Gaber, Ahmed Alhadidi, Qasim Hardy, Ana Maria Gregio Nasr, Abdulrahman Alzahrani, Omar Stary, Creed M. Shah, Zahoor A. Sci Rep Article Drug addiction remains a prevalent and fatal disease worldwide that carries significant social and economic impacts. Recent reports suggest illicit pregabalin (Lyrica) use may be increasing among youth, however the addictive potential of pregabalin has not been well established. Drug seeking behavior and chronic drug use are associated with deficits in glutamate clearance and activation of postsynaptic glutamatergic receptors. In the current study, we investigated the abuse potential of pregabalin using conditioned place preference (CPP) paradigm. Different doses of pregabalin (30, 60, 90, and 120 mg/kg) were used to assess the seeking behavior in mice. Glutamate homeostasis is maintained by glutamate transporter type-1 (GLT-1), which plays a vital role in clearing the released glutamate from synapses and drug seeking behavior. Therefore, we investigated the role of glutamate in pregabalin-seeking behavior with ceftriaxone (CEF), a potent GLT-1 upregulator. Mice treated with pregabalin 60 and 90 mg/kg doses demonstrated drug seeking-like behavior, which was significantly blocked by CEF pretreatment. These results suggest that pregabalin-induced CPP was successfully modulated by CEF which could serve as a lead compound for developing treatment for pregabalin abuse. Nature Publishing Group UK 2019-10-22 /pmc/articles/PMC6805907/ /pubmed/31641170 http://dx.doi.org/10.1038/s41598-019-51556-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Althobaiti, Yusuf S. Almalki, Atiah Alsaab, Hashem Alsanie, Walaa Gaber, Ahmed Alhadidi, Qasim Hardy, Ana Maria Gregio Nasr, Abdulrahman Alzahrani, Omar Stary, Creed M. Shah, Zahoor A. Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
title | Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
title_full | Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
title_fullStr | Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
title_full_unstemmed | Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
title_short | Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism |
title_sort | pregabalin: potential for addiction and a possible glutamatergic mechanism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805907/ https://www.ncbi.nlm.nih.gov/pubmed/31641170 http://dx.doi.org/10.1038/s41598-019-51556-4 |
work_keys_str_mv | AT althobaitiyusufs pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT almalkiatiah pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT alsaabhashem pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT alsaniewalaa pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT gaberahmed pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT alhadidiqasim pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT hardyanamariagregio pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT nasrabdulrahman pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT alzahraniomar pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT starycreedm pregabalinpotentialforaddictionandapossibleglutamatergicmechanism AT shahzahoora pregabalinpotentialforaddictionandapossibleglutamatergicmechanism |